Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical Spectrum of Ras-Associated Autoimmune Leukoproliferative Disorder (RALD).

Journal of clinical immunology - 1 Jan 2021

Neven Quentin, Boulanger Cécile, Bruwier Annelyse, de Ville de Goyet Maëlle, Meyts Isabelle, Moens Leen, Van Damme An, Brichard Bénédicte

Abstract excerpt

Ras-associated autoimmune leukoproliferative disorder (RALD) is a clinical entity initially identified in patients evaluated for an autoimmune lymphoproliferative syndrome (ALPS)-like phenotype. It remains a matter of debate whether RALD is a chronic and benign lymphoproliferative disorder or a pre-malignant condition. We report the case of a 7-year-old girl diagnosed with RALD due to somatic KRAS mutation who...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autoimmune Diseases
Share to Autoimmune Lymphoproliferative Syndrome

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Autoimmunity

Share to Combined Modality Therapy

Share to Disease Management

Share to Karyotype

Share to Myeloproliferative Disorders

Share to ras Proteins

Source

Identifiers

PMID: 33011939
DOI: 10.1007/s10875-020-00883-7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical Spectrum of Ras-Associated Autoimmune Leukoproliferative Disorder (RALD).PMID 33011939Read ↗

JMML and RALD (Ras-associated autoimmune leukoproliferative disorder): common genetic etiology yet clinically distinct entities.Semantic proximity Read ↗

Cutaneous involvement in an 8-year-old boy with Ras-associated autoimmune leucoproliferative disorder (RALD).Semantic proximity Read ↗

Summary and Analysis of 13 RAS-Associated Autoimmune Leukoproliferative Disease Clinical FeaturesSemantic proximity Read ↗

[Ras-associated autoimmune leukoproliferative disorder: a report of 2 cases and literature review].Semantic proximity Read ↗

RAS-associated Autoimmune Leukoproliferative Disease (RALD-KRAS) Consistent with the Clinical Diagnosis of Rosai-Dorfman Disease: A 15-year Follow-up.Semantic proximity Read ↗

Ras‐associated autoimmune lymphoproliferative disorderSemantic proximity Read ↗

Autoimmune lymphoproliferative syndrome-like disease with somatic KRAS mutation.Semantic proximity Read ↗

Type I interferon activation in RAS-associated autoimmune leukoproliferative disease (RALD).Semantic proximity Read ↗

Somatic mosaicism for a NRAS mutation associates with disparate clinical features in RAS-associated leukoproliferative disease: a report of two cases.Semantic proximity Read ↗

Distinct αβ double-negative T cells discriminate between autoimmune lymphoproliferative syndrome and RAS-associated lymphoproliferative diseaseSemantic proximity Read ↗

Case Report: Haemopoietic stem cell transplantation in refractory paediatric RAS-associated lymphoproliferative disorder.Semantic proximity Read ↗

The expanding spectrum of the autoimmune lymphoproliferative syndromes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.